biosimilars

PODCAST: Advances in psoriasis treatmentThe past few years have been an exciting time for those who treat psoriasis and for many patients with severe disease because of excellent new therapies for this often intractable problem. Norman Levine, M.D., talks with Alan Menter, M.D., Baylor University Medical Center, Dallas, about recent developments in the treatment of psoriasis.
Sandoz to test biosimilar for adalimumabSandoz has begun a phase 3 trial of a biosimilar version of adalimumab (Humira, AbbVie) for moderate-to-severe plaque psoriasis.
California governor vetoes biosimilar substitution billWith pharmacy industry bodies, labor unions, and special interest groups arrayed against the bill, Governor Brown returned the legislation to the State Senate unsigned.
Preparing for biosimilarsA short history of biologics and biosimilars, with some pointers on what comes next
PCMA, NCPA blast biosimilars legislation